DLB vs AMTM
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
DLB · Dolby Laboratories$55.33 ▲ 1.02%
AMTM · Amentum Holdings$20.34 ▼ 3.24%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- DLB -15.2%
- AMTM -19.8%
Head to head
| Metric | DLB | AMTM |
|---|---|---|
| Price | $55.33 | $20.34 |
| Change today | ▲ 1.02% | ▼ 3.24% |
| Market cap | $5.13B | $4.97B |
| Return, 3 months | -16.2% | +1.4% |
| Return, year to date | -12.3% | -29.9% |
| Return, 1 year | -16.1% | -16.2% |
| P/E (TTM) | 20.5 | 24.5 |
| P/B | 2.0 | 1.1 |
| P/E percentile vs own 5y | 25th | 39th |
| Dividend yield | 2.60% | – |
| Revenue growth (YoY, latest qtr) | -3.3% | -2.0% |
| Net profit growth (YoY) | -37.2% | +6,700.0% |
| Gross margin | 87.6% | 10.2% |
| Operating margin | 19.3% | 3.6% |
| Net margin | 16.7% | 1.4% |
| Return on equity | 8.7% | 4.5% |
| Analyst target vs. price | +58.1% | +15.5% |
| Analyst buy share | 100% | 0% |
| RSI (14) | 27 | 42 |
| 30-day volatility | 30.1% | 39.9% |
| Max drawdown, 1 year | -29.3% | -51.7% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- DLB is the largest of the group by market value.
- DLB has returned the most over the past year.
- DLB carries the lowest trailing P/E.
- AMTM is growing revenue fastest.
- DLB keeps the most profit per dollar of sales.
- DLB has been the calmest stock over the last 30 days.